FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
11,723 products (finished products)
| Product | Strength | Form · route | Labeler | Application | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|---|---|
| AD Skin Protectant | Lanolin 15.5 g/100g; Petrolatum 53.4 g/100g | OintmentTopical | WellSpring Pharmaceutical Corporation | OTC monograph drug | 65197-470 | 65197-0470-1665197-0470-35 | — |
| Adacel TDaPclostridium tetani toxoid antigen (formaldehyde inactivated), corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated), bordetella pertussis toxoid antigen (glutaraldehyde inactivated), bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated), bordetella pertussis pertactin antigen, and bordetella pertussis fimbriae 2/3 antigen | Clostridium tetani toxoid antigen (Formaldehyde inactivated) 5 [Lf]/.5mL + 5 more ingredients | Injection, SuspensionIntramuscular | Sanofi Vaccines US Inc. | BLA |
| 49281-400 |
| 49281-0400-1049281-0400-20 |
| — |
| Adakveocrizanlizumab | Crizanlizumab 10 mg/mL | InjectionIntravenous | Novartis Pharmaceuticals Corporation | BLA | 0078-0883 | 00078-0883-61 | — |
|---|
| Adalimumabadalimumab-adaz | Adalimumab 80 mg/.8mL | Injection, SolutionSubcutaneous | Sandoz Inc | BLA | 61314-325 | 61314-0325-20 | J0135 |
|---|
| Adalimumabadalimumab-adaz | Adalimumab 40 mg/.4mL | Injection, SolutionSubcutaneous | Sandoz Inc | BLA | 61314-327 | 61314-0327-2061314-0327-64 | J0135 |
|---|
| Adalimumabadalimumab-adaz | Adalimumab 20 mg/.2mL | Injection, SolutionSubcutaneous | Sandoz Inc | BLA | 61314-332 | 61314-0332-64 | J0135 |
|---|
| Adalimumabadalimumab-adaz | Adalimumab 10 mg/.1mL | Injection, SolutionSubcutaneous | Sandoz Inc | BLA | 61314-391 | 61314-0391-64 | J0135 |
|---|
| Adalimumabadalimumab-aaty | — | Kit | CELLTRION USA, Inc. | BLA | 72606-022 | 72606-0022-0172606-0022-0272606-0022-03+9 more | — |
|---|
| Adalimumabadalimumab-aaty | — | Kit | CELLTRION USA, Inc. | BLA | 72606-040 | 72606-0040-0172606-0040-0272606-0040-03+3 more | — |
|---|
| Adalimumabadalimumab-aaty | — | Kit | CELLTRION USA, Inc. | BLA | 72606-041 | 72606-0041-01 | — |
|---|
| Adalimumabadalimumab-fkjp | — | Kit | Biocon Biologics Inc | BLA | 83257-020 | 83257-0020-42 | — |
|---|
| Adalimumabadalimumab-fkjp | — | Kit | Biocon Biologics Inc | BLA | 83257-021 | 83257-0021-42 | — |
|---|
| Adalimumabadalimumab-fkjp | — | Kit | Biocon Biologics Inc | BLA | 83257-022 | 83257-0022-32 | — |
|---|
| Adalimumab-aacfadalimumab | — | KitSubcutaneous | Fresenius Kabi USA, LLC | BLA | 65219-612 | 65219-0612-6965219-0612-8965219-0612-99 | — |
|---|
| Adalimumab-aacfadalimumab | — | KitSubcutaneous | Fresenius Kabi USA, LLC | BLA | 65219-620 | 65219-0620-20 | — |
|---|
| Adalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0545 | 00597-0545-22 | — |
|---|
| Adalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0555 | 00597-0555-80 | — |
|---|
| Adalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0565 | 00597-0565-20 | — |
|---|
| Adalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0575 | 00597-0575-50 | — |
|---|
| Adalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0585 | 00597-0585-89 | — |
|---|
| Adalimumab-adbm | — | Kit | Boehringer Ingelheim Pharmaceuticals, Inc. | BLA | 0597-0595 | 00597-0595-20 | — |
|---|
| Adalimumab-adbm | — | Kit | QUALLENT PHARMACEUTICALS HEALTH LLC | BLA | 82009-144 | 82009-0144-22 | — |
|---|
| Adalimumab-adbm | — | Kit | QUALLENT PHARMACEUTICALS HEALTH LLC | BLA | 82009-146 | 82009-0146-22 | — |
|---|
| Adalimumab-adbm | — | Kit | QUALLENT PHARMACEUTICALS HEALTH LLC | BLA | 82009-148 | 82009-0148-22 | — |
|---|
| Adalimumab-adbm | — | Kit | QUALLENT PHARMACEUTICALS HEALTH LLC | BLA | 82009-150 | 82009-0150-22 | — |
|---|
| Adalimumab-bwwd | Adalimumab 40 mg/.4mL | SolutionSubcutaneous | Cordavis Limited | BLA | 83457-186 | 83457-0186-01 | J0135 |
|---|
| Adalimumab-bwwd | Adalimumab 40 mg/.4mL | SolutionSubcutaneous | Cordavis Limited | BLA | 83457-187 | 83457-0187-01 | J0135 |
|---|
| Adalimumab-ryvk | — | Kit | Teva Pharmaceuticals USA, Inc. | BLA | 51759-310 | 51759-0310-59 | — |
|---|
| Adalimumab-ryvk | — | Kit | Teva Pharmaceuticals USA, Inc. | BLA | 51759-311 | 51759-0311-58 | — |
|---|
| Adalimumab-ryvk | — | Kit | Teva Pharmaceuticals USA, Inc. | BLA | 51759-360 | 51759-0360-02 | — |
|---|
| Adalimumab-ryvk | — | Kit | Teva Pharmaceuticals USA, Inc. | BLA | 51759-361 | 51759-0361-17 | — |
|---|
| Adalimumab-ryvk | — | KitSubcutaneous | Quallent Pharmaceuticals Health LLC | BLA | 82009-156 | 82009-0156-22 | — |
|---|
| Adalimumab-ryvk | — | KitSubcutaneous | Quallent Pharmaceuticals Health LLC | BLA | 82009-158 | 82009-0158-22 | — |
|---|
| Adamas | Diamond 6 [hp_C]/1 | PelletOral | Hahnemann Laboratories, Inc. | Unapproved homeopathic | 63545-382 | 63545-0382-02 | — |
|---|
| Adamas | Diamond 12 [hp_C]/1 | PelletOral | Hahnemann Laboratories, Inc. | Unapproved homeopathic | 63545-747 | 63545-0747-01 | — |
|---|
| Adamas | Diamond 100 [hp_C]/1 | PelletOral | Hahnemann Laboratories, Inc. | Unapproved homeopathic | 63545-749 | 63545-0749-04 | — |
|---|
| Adamas | Diamond 200 [hp_C]/1 | PelletOral | Hahnemann Laboratories, Inc. | Unapproved homeopathic | 63545-750 | 63545-0750-04 | — |
|---|
| Adamas | Diamond 500 [hp_C]/1 | PelletOral | Hahnemann Laboratories, Inc. | Unapproved homeopathic | 63545-751 | 63545-0751-02 | — |
|---|
| Adapalene | Adapalene 1 mg/g | CreamTopical | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | ANDA | 0168-0424 | 00168-0424-46 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | Walgreens | ANDA | 0363-0888 | 00363-0888-0500363-0888-16 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | Walgreens | ANDA | 0363-1401 | 00363-1401-0500363-1401-16 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | Walgreens | ANDA | 0363-4110 | 00363-4110-0500363-4110-16 | — |
|---|
| adapalene | Adapalene 3 mg/g | GelTopical | Actavis Pharma, Inc. | ANDA | 0472-0126 | 00472-0126-45 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | RUGBY LABORATORIES, INC. | ANDA | 0536-1412 | 00536-1412-2000536-1412-26 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | RITE AID | ANDA | 11822-0062 | 11822-0062-01 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | Safeway, Inc. | ANDA | 21130-754 | 21130-0754-05 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | The Kroger Co. | ANDA | 30142-725 | 30142-0725-05 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | MEIJER, INC. | ANDA | 41250-288 | 41250-0288-05 | — |
|---|
| Adapalene | Adapalene .1 g/100g | CreamTopical | Padagis Israel Pharmaceuticals Ltd | NDA authorized generic | 45802-453 | 45802-0453-84 | — |
|---|
| Adapalene | Adapalene 1 mg/g | GelTopical | AMERISOURCE BERGEN | ANDA | 46122-768 | 46122-0768-36 | — |
|---|